Resting Heart Rate and Long-Term Outcomes in Patients with Percutaneous Coronary Intervention: Results from a 10-Year Follow-Up of the CORFCHD-PCI Study

Table 4

Multivariable Cox regression analysis of CM.

Variables	B	SE	Wald	values	HR (95% CI)
Age	0.014	0.007	4.577	0.032	1.014 (1.001–1.027)
SBP	−0.003	0.004	0.354	0.552	0.997 (0.989–1.006)
DBP	−0.004	0.007	0.256	0.613	0.996 (0.982–1.011)
Diabetes	0.119	0.162	0.536	0.464	1.126 (0.820–1.547)
Hypertension	0.126	0.148	0.720	0.396	1.134 (0.848–1.516)
ML	0.565	0.151	14.003	<0.001	1.759 (1.309–2.365)
CTO	0.269	0.162	2.756	0.097	1.309 (0.953–1.798)
Aspirin	−1.914	0.220	75.373	<0.001	0.147 (0.096–0.227)
Statins	−0.891	0.247	13.003	<0.001	0.410 (0.253–0.666)
β-Blockers	−0.799	0.252	10.039	0.002	0.450 (0.274–0.737)
LVEDD	−0.020	0.013	2.256	0.133	0.980 (0.955–1.006)
LVEF	−0.015	0.010	2.238	0.135	0.985 (0.965–1.005)
Heart rate (<66 beats/min as reference)			25.145	<0.001
66–72 beats/min	−0.186	0.275	0.459	0.498	0.830 (0.485–1.423)
72–78 beats/min	−0.090	0.239	0.142	0.707	0.914 (0.572–1.461)
78–84 beats/min	0.451	0.220	4.186	0.041	1.569 (1.019–2.416)
≥84 beats/min	0.687	0.213	10.423	0.001	1.988 (1.310–3.016)